Livforsakringsbolaget Skandia Omsesidigt Has $642,000 Stock Holdings in Agilent Technologies, Inc. (NYSE:A)

Livforsakringsbolaget Skandia Omsesidigt grew its holdings in Agilent Technologies, Inc. (NYSE:A) by 7.8% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,609 shares of the medical research company’s stock after buying an additional 334 shares during the quarter. Livforsakringsbolaget Skandia Omsesidigt’s holdings in Agilent Technologies were worth $642,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently made changes to their positions in A. OFI Invest Asset Management bought a new stake in shares of Agilent Technologies in the 3rd quarter worth about $25,000. Money Concepts Capital Corp bought a new stake in shares of Agilent Technologies in the 4th quarter worth about $26,000. MV Capital Management Inc. grew its holdings in shares of Agilent Technologies by 120.7% in the 4th quarter. MV Capital Management Inc. now owns 192 shares of the medical research company’s stock worth $27,000 after purchasing an additional 105 shares during the last quarter. Ancora Advisors LLC bought a new stake in shares of Agilent Technologies in the 4th quarter worth about $34,000. Finally, Baystate Wealth Management LLC grew its holdings in shares of Agilent Technologies by 107.3% in the 4th quarter. Baystate Wealth Management LLC now owns 257 shares of the medical research company’s stock worth $36,000 after purchasing an additional 133 shares during the last quarter.

Agilent Technologies Stock Performance

Shares of NYSE:A opened at $131.55 on Thursday. The company has a market capitalization of $38.55 billion, a price-to-earnings ratio of 32.04, a P/E/G ratio of 4.14 and a beta of 1.11. The firm’s 50 day simple moving average is $141.22 and its 200 day simple moving average is $129.48. The company has a debt-to-equity ratio of 0.41, a current ratio of 2.68 and a quick ratio of 2.04. Agilent Technologies, Inc. has a fifty-two week low of $96.80 and a fifty-two week high of $151.58.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Tuesday, February 27th. The medical research company reported $1.29 earnings per share for the quarter, beating analysts’ consensus estimates of $1.22 by $0.07. The business had revenue of $1.66 billion for the quarter, compared to the consensus estimate of $1.59 billion. Agilent Technologies had a net margin of 18.35% and a return on equity of 27.09%. Agilent Technologies’s revenue for the quarter was down 5.5% on a year-over-year basis. During the same period last year, the company posted $1.37 EPS. As a group, sell-side analysts forecast that Agilent Technologies, Inc. will post 5.51 earnings per share for the current year.

Agilent Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 24th. Investors of record on Tuesday, April 2nd will be given a $0.236 dividend. The ex-dividend date of this dividend is Monday, April 1st. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.72%. Agilent Technologies’s dividend payout ratio is 22.38%.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on A shares. Barclays upped their target price on shares of Agilent Technologies from $125.00 to $135.00 and gave the stock an “underweight” rating in a report on Wednesday, April 10th. Stifel Nicolaus raised shares of Agilent Technologies from a “hold” rating to a “buy” rating and upped their target price for the stock from $145.00 to $163.00 in a report on Friday, April 5th. Citigroup increased their price objective on shares of Agilent Technologies from $130.00 to $145.00 and gave the stock a “neutral” rating in a report on Wednesday, February 28th. UBS Group increased their price objective on shares of Agilent Technologies from $130.00 to $155.00 and gave the stock a “neutral” rating in a report on Wednesday, February 28th. Finally, Evercore ISI increased their price objective on shares of Agilent Technologies from $132.00 to $145.00 and gave the stock an “in-line” rating in a report on Thursday, April 4th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and twelve have issued a buy rating to the company. According to MarketBeat, Agilent Technologies has an average rating of “Moderate Buy” and a consensus target price of $141.29.

Insider Activity at Agilent Technologies

In related news, Director Heidi Fields sold 1,658 shares of the stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $144.34, for a total value of $239,315.72. Following the sale, the director now directly owns 54,976 shares in the company, valued at approximately $7,935,235.84. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Agilent Technologies news, Director Heidi Fields sold 1,658 shares of the firm’s stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $144.34, for a total transaction of $239,315.72. Following the sale, the director now directly owns 54,976 shares in the company, valued at approximately $7,935,235.84. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Michael R. Mcmullen sold 52,297 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $150.00, for a total transaction of $7,844,550.00. Following the sale, the chief executive officer now owns 253,909 shares in the company, valued at $38,086,350. The disclosure for this sale can be found here. Insiders have sold 61,610 shares of company stock worth $9,220,333 in the last ninety days.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.